Doo Hyung Lee PhD

Mr. Doo H. Lee, Ph.D. Co-founded at Vivozon, Inc. in 2008 and has been its Chief Executive Officer since 2008. Mr. Lee served as Research Scientist at Eli Lilly (Indianapolis, IN), Johnson & Johnson (San Diego, CA) and Amgen (Thousand Oaks, CA) from 1998 to 2007. He served as Vice president at Arisciences, Inc., Seoul, Korea since 2007 until 2008. He served as Visiting Scientist at University of Texas Medical branch, Galveston, TX since 1994 until 1998. He has Expertise in Electrophysiology and vivo pharmacology. He involved in development of duloxetine (Cymbalta, Eli Lilly) and AMG403 (Amgen) Published more than 30 articles in peer-reviewed journals. He holds Ph.D. from Korea University, Seoul, Korea in 1991.